|
BLM expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.44562140036442E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.21389999999611E-05 |
| Normal-vs-Stage2 |
9.740600E-03 |
| Normal-vs-Stage3 |
4.19860000000494E-05 |
| Normal-vs-Stage4 |
6.465700E-02 |
| Stage1-vs-Stage2 |
7.864000E-01 |
| Stage1-vs-Stage3 |
3.677600E-02 |
| Stage1-vs-Stage4 |
1.446230E-01 |
| Stage2-vs-Stage3 |
1.248180E-01 |
| Stage2-vs-Stage4 |
3.618800E-01 |
| Stage3-vs-Stage4 |
8.899600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.2545003337865E-10 |
| Normal-vs-AfricanAmerican |
2.40950000000018E-05 |
| Normal-vs-Asian |
6.530500E-02 |
| Caucasian-vs-AfricanAmerican |
6.470200E-02 |
| Caucasian-vs-Asian |
1.731160E-01 |
| AfricanAmerican-vs-Asian |
1.624040E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.19680043653148E-10 |
| Normal-vs-Female |
2.35969999999863E-05 |
| Male-vs-Female |
4.456100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.963700E-04 |
| Normal-vs-Extreme_Weight |
1.33889999975878E-07 |
| Normal-vs-Obese |
1.19210000004699E-06 |
| Normal-vs-Extreme_Obese |
1.029200E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.710300E-02 |
| Normal_Weight-vs-Obese |
4.444000E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.140200E-03 |
| Extreme_Weight-vs-Obese |
1.782420E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.060080E-02 |
| Obese-vs-Extreme_Obese |
1.479610E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.632500E-04 |
| Normal-vs-Age(41-60Yrs) |
2.18119999839672E-09 |
| Normal-vs-Age(61-80Yrs) |
1.7921999999948E-05 |
| Normal-vs-Age(81-100Yrs) |
1.639720E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.116230E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.544440E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.720300E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.815800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.952480E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.145790E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.42370046044505E-10 |
| Normal-VS-Type2 PRCC |
1.173560E-04 |
| Normal-VS-KIRP CIMP |
9.351500E-04 |
| Normal-VS-Unclassified PRCC |
1.775530E-04 |
| Type1 PRCC-VS-Type2 PRCC |
5.924800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.421100E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
3.141800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.05730000000437E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
6.894600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.356500E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.09590000000071E-05 |
| Normal-vs-N1 |
7.50250000000063E-05 |
| Normal-vs-N2 |
1.003430E-01 |
| N0-vs-N1 |
2.515200E-03 |
| N0-vs-N2 |
6.949000E-01 |
| N1-vs-N2 |
2.337800E-01 |
|
|
